• 1. An atom-economical protocol for direct conversion of Baylis–Hillman alcohols to β-chloro aldehydes in water?
  Raktani Bikshapathi,Sai Prathima Parvathaneni,Vaidya Jayathirtha Rao Green Chem., 2017,19, 4446-4450
• 2. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 3. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 4. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 5. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003

• Solvents and Organic Chemicals Organic Compounds Amines/Sulfonamides

Comprehensive Guide to 1-(4-(Aminomethyl)phenyl)-N,N-dimethylmethanamine hydrochloride (CAS No. 242452-35-3)

1-(4-(Aminomethyl)phenyl)-N,N-dimethylmethanamine hydrochloride (CAS 242452-35-3) is a specialized organic compound with significant potential in pharmaceutical and biochemical research. This compound, often referred to in scientific literature by its systematic name, features a unique molecular structure combining an aminomethylphenyl group with a dimethylmethanamine moiety, making it a subject of interest for drug discovery and material science applications.

The compound's hydrochloride salt form enhances its stability and solubility, which is crucial for laboratory and industrial applications. Researchers are particularly interested in its potential as a building block for more complex molecules, especially in the development of novel pharmaceutical intermediates. With the growing demand for precision medicine and targeted therapies, compounds like 1-(4-(Aminomethyl)phenyl)-N,N-dimethylmethanamine hydrochloride are gaining attention in the scientific community.

One of the most frequently asked questions about this compound relates to its synthesis pathway. The production typically involves multi-step organic reactions, starting from readily available precursors. The CAS 242452-35-3 compound is often synthesized through a series of amination and alkylation reactions, followed by salt formation with hydrochloric acid. This process requires careful control of reaction conditions to ensure high purity and yield.

In terms of physicochemical properties, 1-(4-(Aminomethyl)phenyl)-N,N-dimethylmethanamine hydrochloride typically appears as a white to off-white crystalline powder. It shows good solubility in water and polar organic solvents, which is advantageous for various formulation applications. The compound's molecular weight and structural features make it suitable for further chemical modifications, a property highly valued in medicinal chemistry research.

The pharmacological potential of this compound is currently under investigation in several research institutions. While not yet approved for therapeutic use, preliminary studies suggest possible applications in neurological research and receptor modulation. The presence of both amino and dimethylamino functional groups in its structure makes it a candidate for interaction with various biological targets.

From a market perspective, the demand for CAS 242452-35-3 has been steadily increasing, particularly from contract research organizations and pharmaceutical developers. The compound is typically supplied in small to medium quantities for research purposes, with purity levels ranging from 95% to 99%. Current research trends in personalized medicine and drug repurposing are expected to drive further interest in this and similar compounds.

Quality control for 1-(4-(Aminomethyl)phenyl)-N,N-dimethylmethanamine hydrochloride involves rigorous analytical testing, including HPLC, NMR, and mass spectrometry verification. These methods ensure the compound meets the stringent requirements of research applications. Storage recommendations typically include protection from moisture and maintenance at controlled room temperature to preserve stability.

For researchers working with this compound, proper handling procedures should always be followed, including the use of appropriate personal protective equipment. While not classified as hazardous under normal conditions, standard laboratory safety protocols apply when handling any chemical substance. The compound's material safety data sheet (MSDS) provides detailed information about its proper handling and storage.

The future outlook for 1-(4-(Aminomethyl)phenyl)-N,N-dimethylmethanamine hydrochloride appears promising, with potential applications extending beyond current research scope. As drug discovery methods become more sophisticated and computational chemistry tools more advanced, compounds with such versatile structures are likely to see increased utilization in various stages of pharmaceutical development.

In conclusion, CAS 242452-35-3 represents an interesting example of how specialized organic compounds contribute to advancing scientific research. Its unique structural features and potential applications make it a valuable subject for ongoing investigation in multiple fields of chemistry and pharmacology. As research continues, we may discover even more significant applications for this versatile compound in the coming years.

• 19171-43-8(1,4-Benzenedimethanaminium,N1,N1,N1,N4,N4,N4-hexaethyl-, chloride (1:2))
• 13426-94-3(N-Methylbenzylamine Hydrochloride)
• 51834-90-3(Benzenemethanamine, N,N-diethyl-, hydrochloride)
• 1875-92-9(Benzenemethanamine,N,N-dimethyl-, hydrochloride (1:1))
• 34490-85-2(4-(Aminomethyl)benzyldimethylamine Dihydrochloride)
• 23539-76-6(1,3,5-Benzenetrimethanamine,N1,N1,N3,N3,N5,N5-hexamethyl-)
• 56-93-9(Benzyltrimethylammonium chloride)
• 100-94-7(Dibenzyl dimethylammonium chloride)
• 56-37-1(benzyltriethylazanium chloride)
• 28262-13-7(Benzenemethanamine,dimethyl- (9CI))